A Manchester Royal Infirmary doctor and researcher has coordinated a national team of experts to publish guidance for clinicians to help them safely manage hyperlipidaemia patients during the pandemic
In January, Jesha Mathews was named as one of the highly commended members of Research and Innovation staff for 2020: Year of the Nurse and Midwife. She reflects on her year in this blog.
In January, Sindhu John was named as one of the highly commended members of Research and Innovation staff for 2020: Year of the Nurse and Midwife. She reflects on her year in this blog.
A Manchester man hospitalised with COVID-19 in the early days of the pandemic is now giving back to the NHS by taking part in research – and is encouraging others to do the same.
Dr Claire Cole, the Head of Research Delivery at MFT – one of the sites where the Janssen Phase 3 trial is being conducted in the UK – was the first person consented into the trial in the world.
Cellular (T-cell) immunity against SARS-CoV-2 is likely to be present within most adults for at least six months after infection, according to research carried out at MFT.
A lung cancer patient at Wythenshawe Hospital has taken part in a national project led by Manchester researchers, investigating changes in radiotherapy treatments during COVID-19.
The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.